Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MALIGNANT MESOTHELIOMA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 731 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fetsch, PA; Simsir, A; Abati, A
      Comparison of antibodies to HBME-1 and calretinin for the detection of mesothelial cells in effusion cytology

      DIAGNOSTIC CYTOPATHOLOGY
    2. Weiser, TS; Guo, ZS; Ohnmacht, GA; Parkhurst, ML; Tong-On, P; Marincola, FM; Fischette, MR; Yu, XD; Chen, GA; Hong, JA; Stewart, JH; Nguyen, DM; Rosenberg, SA; Schrump, DS
      Sequential 5-aza-2 '-deoxycytidine-depsipeptide FR901228 treatment inducesapoptosis preferentially in cancer cells and facilitates their recognitionby cytolytic T lymphocytes specific for NY-ESO-1

      JOURNAL OF IMMUNOTHERAPY
    3. Mroczko, B; Szmitkowski, M; Niklinski, J
      Granulocyte-colony stimulating factor and macrophage-colony stimulating factor in patients with non-small-cell lung cancer

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    4. Faust, R
      The modular approach to acetylenic phthalocyanines and phthalocyanine analogues

      EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
    5. Mullauer, L; Gruber, P; Sebinger, D; Buch, J; Wohlfart, S; Chott, A
      Mutations in apoptosis genes: a pathogenetic factor for human disease

      MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
    6. Suzuki, M; Piao, CQ; Zhao, YL; Hei, TK
      Karyotype analysis of tumorigenic human bronchial epithelial cells transformed by chrysolite asbestos using chemically induced premature chromosome condensation technique

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    7. Jasani, B; Jones, CJ; Radu, C; Wynford-Thomas, D; Navabi, H; Mason, M; Adams, M; Gibbs, A
      Simian virus 40 detection in human mesothelioma: Reliability and significance of the available molecular evidence

      FRONTIERS IN BIOSCIENCE
    8. Rowland-Goldsmith, MA; Maruyama, H; Kusama, T; Ralli, S; Korc, M
      Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation

      CLINICAL CANCER RESEARCH
    9. Khokhar, NZ; She, Y; Rusch, VW; Sirotnak, FM
      Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: Further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases, and combined therapy with platinums

      CLINICAL CANCER RESEARCH
    10. Agoff, SN; Grieco, VS; Garcia, R; Gown, AM
      Immunohistochemical distinction of endometrial stromal sarcoma and cellular leiomyoma

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    11. Cohn, DE; Mutch, DG; Elbendary, A; Rader, JS; Herzog, TJ; Goodfellow, P
      No evidence for BCL10 mutations in endometrial cancers with microsatelliteinstability

      HUMAN MUTATION
    12. Zhang, RS; Straus, FH; DeGroot, LJ
      Adenoviral-mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specificity and low toxicity

      THYROID
    13. Rizzo, P; Bocchetta, M; Powers, A; Foddis, R; Stekala, E; Pass, HI; Carbone, M
      SV40 and the pathogenesis of mesothelioma

      SEMINARS IN CANCER BIOLOGY
    14. Schrump, DS; Waheed, I
      Strategies to circumvent SV40 oncoprotein expression in malignant pleural mesotheliomas

      SEMINARS IN CANCER BIOLOGY
    15. Imperiale, MJ; Pass, HI; Sanda, MG
      Prospects for an SV40 vaccine

      SEMINARS IN CANCER BIOLOGY
    16. Yasukawa, M
      Immunotherapy for leukemia targeting the Wilms' tumor gene

      LEUKEMIA & LYMPHOMA
    17. Katano, K; Tsujitani, S; Maeta, M; Fukuda, K; Oka, S; Hisamitsu, K; Ikeguchi, M; Kaibara, N
      Pharmacokinetics of intraoperative intrapleural cisplatin chemotherapy of various osmolarities in cases of esophageal cancer

      ONCOLOGY REPORTS
    18. Strizzi, L; Vianale, G; Catalano, A; Muraro, R; Mutti, L; Procopio, A
      Basic fibroblast growth factor in mesothelioma pleural effusions: Correlation with patient survival and angiogenesis

      INTERNATIONAL JOURNAL OF ONCOLOGY
    19. Maggi, G; Casadio, C; Cianci, R; Rena, O; Ruffini, E
      Trimodality management of malignant pleural mesothelioma

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    20. Lambright, ES; Amin, K; Wiewrodt, R; Force, SD; Lanuti, M; Propert, KJ; Litzky, L; Kaiser, LR; Albelda, SM
      Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy

      GENE THERAPY
    21. Gomes, ML; de Mattos, DMM; Freitas, RD; Bezerra, RJAC; Bernardo-Filho, M
      Study of the toxicological effect of mitomycin C in mice: alteration on the biodistribution of radiopharmaceuticals used for renal evaluations

      HUMAN & EXPERIMENTAL TOXICOLOGY
    22. Gillespie, FR; Van der Walt, JD; Derias, N; Kenney, A
      Deciduoid peritoneal mesothelioma. A report of the cytological appearances

      CYTOPATHOLOGY
    23. Vivo, C; Levy, F; Pilatte, Y; Fleury-Feith, J; Chretien, P; Monnet, I; Kheuang, L; Jaurand, MC
      Control of cell cycle progression in human mesothelioma cells treated withgamma interferon

      ONCOGENE
    24. De Rienzo, A; Balsara, BR; Apostolou, S; Jhanwar, SC; Testa, JR
      Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma

      ONCOGENE
    25. Shigemitsu, K; Sekido, Y; Usami, N; Mori, S; Sato, M; Horio, Y; Hasegawa, Y; Bader, SA; Gazdar, AF; Minna, JD; Hida, T; Yoshioka, H; Imaizumi, M; Ueda, Y; Takahashi, M; Shimokata, K
      Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion

      ONCOGENE
    26. Kuwahara, M; Takeda, M; Takeuchi, Y; Kuwahara, M; Harada, T; Maita, K
      Transforming growth factor beta production by spontaneous malignant mesothelioma cell lines derived from Fisher 344 rats

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    27. Mohiuddin, M; Cao, XB; Fang, BL; Nishizaki, M; Smythe, WR
      Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma

      CANCER GENE THERAPY
    28. Mukherjee, S; Nelson, D; Loh, S; van Bruggen, I; Palmer, LJ; Leong, C; Garlepp, MJ; Robinson, BWS
      The immune anti-tumor effects of GM-CSF and B7-1 gene transfection are enhanced by surgical debulking of tumor

      CANCER GENE THERAPY
    29. Sugiyama, H
      Wilms' tumor gene WT1: Its oncogenic function and clinical application

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    30. Tadokoro, J; Nakamura, Y; Furusawa, S; Mitani, K
      Low frequency of BCL10 gene mutations in B-Cell non-Hodgkin's lymphoma

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    31. Steele, JPC; O'Doherty, CA; Shamash, J; Evans, MT; Gower, NH; Tischkowitz, MD; Rudd, RM
      Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma

      ANNALS OF ONCOLOGY
    32. Shmueli, E; Leider-Trejo, L; Schwartz, I; Aderka, D; Inbar, M
      Primary papillary serous carcinoma of the peritoneum in a man

      ANNALS OF ONCOLOGY
    33. Dumortier, P; Gocmen, A; Laurent, K; Manco, A; De Vuyst, P
      The role of environmental and occupational exposures in Turkish immigrantswith fibre-related disease

      EUROPEAN RESPIRATORY JOURNAL
    34. Ravenel, JG; McAdams, HP; Remy-Jardin, M; Remy, J
      Multidimensional imaging of the thorax

      JOURNAL OF THORACIC IMAGING
    35. Sebbag, G; Sugarbaker, PH
      Peritoneal mesothelioma proposal for a staging system

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    36. Amin, AMH; Mason, C; Rowe, P
      Diffuse malignant mesothelioma of the peritoneum following abdominal radiotherapy

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    37. Pujolar, AE; Gonzalez, C; Agudo, A; Calleja, A; Beltran, M; Gonzalez-Moya, J; Hernandez, S; Panades, R; Ramirez, J; Turuguet, D
      Information about occupational exposure to asbestos given to cases in an etiological study: Ethical aspects

      EUROPEAN JOURNAL OF EPIDEMIOLOGY
    38. Bandoh, S; Fujita, J; Fukunaga, Y; Ohtsuka, S; Susaki, K; Yang, Y; Kobayashi, S; Takahara, J
      Nodular thickening of interlobar fissures: an early manifestation of malignant mesothelioma: A case report

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    39. Leonardo, E; Zanconati, F; Bonifacio, D; Di Bonito, L
      Immunohistochemical MIB-1 and p27(kip1) as prognostic factors in pleural mesothelioma

      PATHOLOGY RESEARCH AND PRACTICE
    40. Neumann, V; Gunther, S; Muller, KM; Fischer, M
      Malignant mesothelioma - German mesothelioma register 1987-1999

      INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH
    41. Gonzalez-Lois, C; Ballestin, C; Sotelo, MT; Lopez-Rios, F; Garcia-Prats, MD; Villena, V
      Combined use of novel epithelial (MOC-31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura

      HISTOPATHOLOGY
    42. Beer, TW; Shepherd, P; Pullinger, NC
      p27 immunostaining is related to prognosis in malignant mesothelioma

      HISTOPATHOLOGY
    43. Mitropoulou, TN; Theocharis, AD; Stagiannis, KD; Karamanos, NK
      Identification, quantification and fine structural characterization of glycosaminoglycans from uterine leiomyoma and normal myometrium

      BIOCHIMIE
    44. Pinto, C; Marino, A; Guaraldi, M; Melotti, B; Piana, E; Martoni, A; Pannuti, F
      Combination chemotherapy with mitoxantrone, methotrexate, and mitomycin (MMM regimen) in malignant pleural mesothelioma - A phase II study

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    45. Wong, O
      Malignant mesothelioma and asbestos exposure among auto mechanics: Appraisal of scientific evidence

      REGULATORY TOXICOLOGY AND PHARMACOLOGY
    46. Makatsori, E; Karamanos, NK; Papadogiannakis, N; Hjerpe, A; Anastassiou, ED; Tsegenidis, T
      Synthesis and distribution of glycosaminoglycans in human leukemic B- and T-cells and monocytes studied using specific enzymic treatments and high-performance liquid chromatography

      BIOMEDICAL CHROMATOGRAPHY
    47. Inase, N; Miyake, S; Yoshizawa, Y
      Calretinin promoter for suicide gene expression in malignant mesothelioma

      ANTICANCER RESEARCH
    48. Chalabreysse, L; Guillaud, C; Tabib, A; Loire, R; Thivolet-Bejui, F
      Malignant mesothelioma with osteoblastic heterologous elements

      ANNALES DE PATHOLOGIE
    49. Rigau, V; Martel, B; Evrard, C; Rousselot, P; Galateau-Salle, F
      HBME-1 immunostaining in thyroid pathology

      ANNALES DE PATHOLOGIE
    50. Tandar, A; Abraham, G; Gurka, J; Wendel, M; Stolbach, L
      Recurrent peritoneal mesothelioma with long-delayed recurrence

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    51. Robinson, BWS; Robinson, C; Lake, RA
      Localised spontaneous regression in mesothelioma - possible immunological mechanism

      LUNG CANCER
    52. Quoix, E; Chenard, MP; Orion, B; Lang-Averous, G; Dopff-Kaissling, A
      A left pleural effusion with a calcified tumoral mass and left hemithoracic uptake on bone scan

      LUNG CANCER
    53. Alatas, F; Alatas, O; Metintas, M; Colak, O; Harmanci, E; Demir, S
      Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions

      LUNG CANCER
    54. Takagi, K; Tsuchiya, R; Watanabe, Y
      Surgical approach to pleural diffuse mesothelioma in Japan

      LUNG CANCER
    55. Sandberg, AA; Bridge, JA
      Updates on the cytogenetics and molecular genetics of bone and soft tissuetumors. Mesothelioma

      CANCER GENETICS AND CYTOGENETICS
    56. Aubry, MC; Bridge, JA; Wickert, R; Tazelaar, HD
      Primary monophasic synovial sarcoma of the pleura - Five cases confirmed by the presence of SYT-SSX fusion transcript

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    57. Davidson, B; Nielsen, S; Christensen, J; Asschenfeldt, P; Berner, A; Risberg, B; Johansen, P
      The role of desmin and N-cadherin in effusion cytology - A comparative study using established markers of mesothelial and epithelial cells

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    58. Carella, R; Deleonardi, G; D'Errico, A; Salerno, A; Egarter-Vigl, E; Seebacher, C; Donazzan, G; Grigioni, WF
      Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma - A study with logistic regression analysis

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    59. Comin, CE; Novelli, L; Boddi, V; Paglierani, M; Dini, S
      Calretinin, thrombomodulin, CEA, and CD15: A useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma

      HUMAN PATHOLOGY
    60. Schneider, J; Woitowitz, HJ
      Asbestos associated mesothelioma of the tunica vaginalis testis

      ZENTRALBLATT FUR CHIRURGIE
    61. Farmer, CKT; Goldsmith, DJA
      Nephrotic syndrome and mesenteric infarction secondary to metastatic mesothelioma

      POSTGRADUATE MEDICAL JOURNAL
    62. Dahlstrom, JE; Maxwell, LE; Brodie, N; Zardawi, IM; Jain, S
      Distinctive microvillous brush border staining with HBME-1 distinguishes pleural mesotheliomas from pulmonary adenocarcinomas

      PATHOLOGY
    63. Cappello, F; Barnes, L
      Synovial sarcoma and malignant mesothelioma of the pleura: Review, differential diagnosis and possible role of apoptosis

      PATHOLOGY
    64. Kobayashi, S; Ida, M; Matsui, O; Kuroda, E; Isobe, T; Matsubara, F
      Lipomatous change in a brain metastasis from malignant pleural mesothelioma

      NEURORADIOLOGY
    65. Pataer, A; Smythe, WR; Yu, R; Fang, BL; McDonnell, T; Roth, JA; Swisher, SG
      Adenovirus-mediated Bak gene transfer induces apoptosis in mesothelioma cell lines

      JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
    66. Strizzi, L; Catalano, A; Vianale, G; Orecchia, S; Casalini, A; Tassi, G; Puntoni, R; Mutti, L; Procopio, A
      Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma

      JOURNAL OF PATHOLOGY
    67. Kayser, K; Bohm, G; Blum, S; Beyer, M; Zink, S; Andre, S; Gabius, HJ
      Glyco- and immunohistochemical refinement of the differential diagnosis between mesothelioma and metastatic carcinoma and survival analysis of patients

      JOURNAL OF PATHOLOGY
    68. Rubins, JB; Charboneau, D; Alter, MD; Bitterman, PB; Kratzke, RA
      Inhibition of mesothelioma cell growth in vitro by doxycycline

      JOURNAL OF LABORATORY AND CLINICAL MEDICINE
    69. Roberts, F; McCall, AE; Burnett, RA
      Malignant mesothelioma: a comparison of biopsy and postmortem material by light microscopy and immunohistochemistry

      JOURNAL OF CLINICAL PATHOLOGY
    70. Liu, ZW; Ivanoff, A; Klominek, J
      Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines

      INTERNATIONAL JOURNAL OF CANCER
    71. Kettunen, E; Nissen, AM; Ollikainen, T; Taavitsainen, M; Tapper, J; Mattson, K; Linnainmaa, K; Knuutila, S; El-Rifai, W
      Gene expression profiling of malignant mesothelioma cell lines: cDNA arraystudy

      INTERNATIONAL JOURNAL OF CANCER
    72. Schouwink, H; Rutgers, ET; van der Sijp, J; Oppelaar, H; van Zandwijk, N; van Veen, R; Burgers, S; Stewart, FA; Zoetmulder, F; Baas, P
      Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma - Dose finding and toxicity results

      CHEST
    73. Paganuzzi, M; Onetto, M; Marroni, P; Filiberti, R; Tassara, E; Parodi, S; Felletti, R
      Diagnostic value of CYFRA 21-1 turner marker end CEA in pleural effusion due to mesothelioma

      CHEST
    74. Kasuga, I; Ishizuka, S; Minemura, K; Utsumi, K; Serizawa, H; Ohyashiki, K
      Malignant pleural mesothelioma produces functional granulocyte-colony stimulating factor

      CHEST
    75. Yang, CT; You, L; Uematsu, K; Yeh, CC; McCormick, F; Jablons, DM
      p14(ARF) modulates the cytolytic effect of ONYX-015 in mesothelioma cells with wild-type p53

      CANCER RESEARCH
    76. Odaka, M; Sterman, DH; Wiewrodt, R; Zhang, Y; Kiefer, M; Amin, KM; Gao, GP; Wilson, JM; Barsoum, J; Kaiser, LR; Albelda, SM
      Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity

      CANCER RESEARCH
    77. Liu, NF; Gao, F; Han, ZQ; Xu, XM; Underhill, CB; Zhang, LR
      Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells

      CANCER RESEARCH
    78. Fetsch, PA; Abati, A
      Immunocytochemistry in effusion cytology - A contemporary review

      CANCER CYTOPATHOLOGY
    79. Chhieng, DC; Cangiarella, JF; Zakowski, MF; Goswami, S; Cohen, JM; Yee, HT
      Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 indiscriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens

      CANCER CYTOPATHOLOGY
    80. Lozano, MD; Panizo, A; Toledo, GR; Sola, JJ; Pardo-Mindan, J
      Immunocytochemistry in the differential diagnosis of serous effusions - A comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears

      CANCER CYTOPATHOLOGY
    81. Yellin, A; Simansky, DA; Paley, M; Refaely, Y
      Hyperthermic pleural perfusion with cisplatin - Early clinical experience

      CANCER
    82. Thylen, A; Hjerpe, A; Martensson, G
      Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma

      CANCER
    83. Bongiovanni, M; Cassoni, P; De Giuli, P; Viberti, L; Cappia, S; Ivaldi, G; Chiusa, L; Bussolati, G
      p27(kip1) Immunoreactivity correlates with long-term survival in pleural malignant mesothelioma

      CANCER
    84. Parra, HS; Tixi, L; Latteri, F; Bretti, S; Alloisio, M; Gravina, A; Lionetto, R; Bruzzi, P; Dani, C; Rosso, R; Cosso, M; Balzarini, L; Santoro, A; Ardizzoni, A
      Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in thetreatment of advanced malignant pleural mesothelioma - A phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP)

      CANCER
    85. Browne, K; Wagner, JC
      Environmental exposure to amphibole-asbestos and mesothelioma

      CANADIAN MINERALOGIST
    86. Baldi, F; Baldi, A; Giordano, G; Giordano, A
      p53 and the retinoblastoma gene family in human mesothelioma: The SV40 hypothesis

      CANADIAN MINERALOGIST
    87. Higashi, T; Takahashi, K
      Asbestos and environmental health in Japan

      CANADIAN MINERALOGIST
    88. Mohr, S; Rihn, B
      Profiling gene expression in human mesothelioma cells using DNA microarrayand high-density filter array technologies

      BULLETIN DU CANCER
    89. Blackhall, FH; Merry, CLR; Davies, EJ; Jayson, GC
      Heparan sulfate proteoglycans and cancer

      BRITISH JOURNAL OF CANCER
    90. Edwards, JG; Cox, G; Andi, A; Jones, JL; Walker, RA; Waller, DA; O'Byrne, KJ
      Angiogenesis is an independent prognostic factor in malignant mesothelioma

      BRITISH JOURNAL OF CANCER
    91. Li, Y; Heldin, P
      Hyaluronan production increases the malignant properties of mesothelioma cells

      BRITISH JOURNAL OF CANCER
    92. Holtzman, RNN; Heymann, AD; Bordone, F; Marinoni, G; Barillari, P; Wahl, SJ
      Carbohydrate antigen 19-9 and carcinoembryonic antigen immunostaining in benign multicystic mesothelioma of the peritoneum

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    93. Murai, Y
      Malignant mesothelioma in Japan: Analysis of registered autopsy cases

      ARCHIVES OF ENVIRONMENTAL HEALTH
    94. Benchekroun, A; Jira, H; Ghadouane, M; Kasmaoui, EH; Marzouk, M; Faik, M
      Malignant mesothelioma of the tunica vaginalis. A new case report.

      ANNALES D UROLOGIE
    95. Ko, EC; Jhala, NC; Shultz, JJ; Chhieng, DC
      Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology

      AJCP. American journal of clinical pathology
    96. Laurini, JA; Garcia, A; Elsner, B; Bellotti, M; Rescia, C
      Relation between natural killer cells and neoplastic cells in serous fluids

      DIAGNOSTIC CYTOPATHOLOGY
    97. Imlay, SP; Raab, SS
      Pleural fluid cytology: Immunocytochemistry usage patterns and significance of nondefinitive diagnoses

      DIAGNOSTIC CYTOPATHOLOGY
    98. Lee, A; Baloch, ZW; Yu, G; Gupta, PK
      Mesothelial hyperplasia with reactive atypia: Diagnostic pitfalls and roleof immunohistochemical studies - A case report

      DIAGNOSTIC CYTOPATHOLOGY
    99. Ariad, S; Barchana, M; Yukelson, A; Geffen, DB
      A worrying increase in the incidence of mesothelioma in Israel

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    100. Krismann, M; Muller, KM; Jaworska, M; Johnen, G
      Severe chromosomal aberrations in pleural mesotheliomas with unusual mesodermal features - Comparative genomic hybridization evidence for a mesothelioma subgroup

      JOURNAL OF MOLECULAR DIAGNOSTICS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 12:41:51